rs142148876

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_000264.5(PTCH1):​c.4128C>T​(p.Ser1376Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000943 in 1,613,274 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. S1376S) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00069 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00097 ( 7 hom. )

Consequence

PTCH1
NM_000264.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:16

Conservation

PhyloP100: -2.38

Publications

2 publications found
Variant links:
Genes affected
PTCH1 (HGNC:9585): (patched 1) This gene encodes a member of the patched family of proteins and a component of the hedgehog signaling pathway. Hedgehog signaling is important in embryonic development and tumorigenesis. The encoded protein is the receptor for the secreted hedgehog ligands, which include sonic hedgehog, indian hedgehog and desert hedgehog. Following binding by one of the hedgehog ligands, the encoded protein is trafficked away from the primary cilium, relieving inhibition of the G-protein-coupled receptor smoothened, which results in activation of downstream signaling. Mutations of this gene have been associated with basal cell nevus syndrome and holoprosencephaly. [provided by RefSeq, Aug 2017]
PTCH1 Gene-Disease associations (from GenCC):
  • basal cell nevus syndrome 1
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • holoprosencephaly 7
    Inheritance: AD Classification: DEFINITIVE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • nevoid basal cell carcinoma syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, ClinGen, Orphanet, Labcorp Genetics (formerly Invitae)
  • holoprosencephaly
    Inheritance: AD Classification: LIMITED Submitted by: Illumina

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.36).
BP6
Variant 9-95447128-G-A is Benign according to our data. Variant chr9-95447128-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 135898.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.38 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.000689 (105/152346) while in subpopulation SAS AF = 0.00641 (31/4834). AF 95% confidence interval is 0.00464. There are 0 homozygotes in GnomAd4. There are 61 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 105 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000264.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PTCH1
NM_000264.5
MANE Select
c.4128C>Tp.Ser1376Ser
synonymous
Exon 23 of 24NP_000255.2Q13635-1
PTCH1
NM_001083603.3
MANE Plus Clinical
c.4125C>Tp.Ser1375Ser
synonymous
Exon 23 of 24NP_001077072.1Q13635-2
PTCH1
NM_001354918.2
c.3972C>Tp.Ser1324Ser
synonymous
Exon 22 of 23NP_001341847.1A0A1W5YLI7

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PTCH1
ENST00000331920.11
TSL:5 MANE Select
c.4128C>Tp.Ser1376Ser
synonymous
Exon 23 of 24ENSP00000332353.6Q13635-1
PTCH1
ENST00000437951.6
TSL:5 MANE Plus Clinical
c.4125C>Tp.Ser1375Ser
synonymous
Exon 23 of 24ENSP00000389744.2Q13635-2
PTCH1
ENST00000429896.6
TSL:1
c.3675C>Tp.Ser1225Ser
synonymous
Exon 23 of 24ENSP00000414823.2Q13635-4

Frequencies

GnomAD3 genomes
AF:
0.000677
AC:
103
AN:
152228
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00548
Gnomad AMR
AF:
0.000393
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000964
Gnomad SAS
AF:
0.00641
Gnomad FIN
AF:
0.000753
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000588
Gnomad OTH
AF:
0.000957
GnomAD2 exomes
AF:
0.00142
AC:
352
AN:
247144
AF XY:
0.00166
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000406
Gnomad ASJ exome
AF:
0.000402
Gnomad EAS exome
AF:
0.00110
Gnomad FIN exome
AF:
0.000926
Gnomad NFE exome
AF:
0.00100
Gnomad OTH exome
AF:
0.00198
GnomAD4 exome
AF:
0.000970
AC:
1417
AN:
1460928
Hom.:
7
Cov.:
30
AF XY:
0.00114
AC XY:
828
AN XY:
726794
show subpopulations
African (AFR)
AF:
0.000209
AC:
7
AN:
33478
American (AMR)
AF:
0.000403
AC:
18
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
0.000268
AC:
7
AN:
26114
East Asian (EAS)
AF:
0.000554
AC:
22
AN:
39696
South Asian (SAS)
AF:
0.00548
AC:
473
AN:
86246
European-Finnish (FIN)
AF:
0.000570
AC:
30
AN:
52664
Middle Eastern (MID)
AF:
0.00537
AC:
31
AN:
5768
European-Non Finnish (NFE)
AF:
0.000687
AC:
764
AN:
1111888
Other (OTH)
AF:
0.00108
AC:
65
AN:
60368
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
101
202
303
404
505
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000689
AC:
105
AN:
152346
Hom.:
0
Cov.:
32
AF XY:
0.000819
AC XY:
61
AN XY:
74506
show subpopulations
African (AFR)
AF:
0.000120
AC:
5
AN:
41590
American (AMR)
AF:
0.000457
AC:
7
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00116
AC:
6
AN:
5174
South Asian (SAS)
AF:
0.00641
AC:
31
AN:
4834
European-Finnish (FIN)
AF:
0.000753
AC:
8
AN:
10628
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000588
AC:
40
AN:
68028
Other (OTH)
AF:
0.000947
AC:
2
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
6
11
17
22
28
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000730
Hom.:
0
Bravo
AF:
0.000601
Asia WGS
AF:
0.00260
AC:
9
AN:
3478
EpiCase
AF:
0.00109
EpiControl
AF:
0.00113

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
not specified (5)
-
-
4
not provided (4)
-
-
3
Gorlin syndrome (3)
-
-
2
Hereditary cancer-predisposing syndrome (2)
-
-
1
Holoprosencephaly 7 (1)
-
-
1
Holoprosencephaly 7;C2751544:Basal cell carcinoma, susceptibility to, 1;CN376810:Basal cell nevus syndrome 1 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.36
CADD
Benign
2.8
DANN
Benign
0.77
PhyloP100
-2.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs142148876; hg19: chr9-98209410; API